meglumine antimoniate has been researched along with urea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barão, SC; Giorgio, S | 1 |
| Armijos, RX; Calvopiña, M; Mancheno, M; Rodriguez, R; Weigel, MM | 1 |
| Broere, F; de Jong, MK; Piek, CJ; Rappoldt, A | 1 |
1 trial(s) available for meglumine antimoniate and urea
| Article | Year |
|---|---|
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Double-Blind Method; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Urea | 2004 |
2 other study(ies) available for meglumine antimoniate and urea
| Article | Year |
|---|---|
Efficacy of 8-bromoguanosine against murine cutaneous leishmaniasis induced with Leishmania amazonensis.
Topics: Alanine Transaminase; Animals; Female; Guanosine; Hematologic Tests; Injections, Intraperitoneal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Organometallic Compounds; Skin Ulcer; Trypanocidal Agents; Urea | 2003 |
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
Topics: Allopurinol; Animals; Creatinine; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Prognosis; Recurrence; Urea | 2023 |